Non-24 hour sleep-wake cycle
Name | Development Level | Target Family |
---|
Name | Description |
---|---|
tasimelteon | an agonist at melatonin MT1 and MT2 receptors, these receptors are thought to be involved in the control of circadian rhythms |
TCRDv4.6.9
DrugCentral Indication
DrugCentral
tasimelteon
DrugCentral Indication
DrugCentral
tasimelteon